“This acquisition adds not only to our commercial portfolio and reinforces our leading position in travel vaccines, but it also strengthens our pipeline with a promising late-stage vaccine candidate ...

Add Yahoo as a preferred source to see more of our stories on Google. evening sunset over town square in Munich Germany Munich, Germany is often an underrated destination with Bavarian history, ...

Feb 15 (Reuters) - Danish pharmaceuticals company Bavarian Nordic (BAVA.CO), opens new tab has agreed to buy a portfolio of travel vaccines from Emergent BioSolutions Inc (EBS.N), opens new tab for up ...

COPENHAGEN, Denmark, May 15, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today that it has completed its acquisition of the travel vaccine portfolio from Emergent BioSolutions Inc. (NYSE: EBS) ...

Bavarian Nordic A/S plans to buy two travel vaccines plus a phase III chikungunya vaccine candidate from Emergent Biosolutions Inc. for about $380 million. Emergent will receive a $270 million ...

COPENHAGEN, Denmark, March 12, 2026 - Bavarian Nordic A/S (OMX: BAVA) today published its annual report for 2025. The consolidated, audited results were in line with the preliminary results announced ...

Germany's Oktoberfest is a legendary annual event, taking place in Munich, the European gem that's considered the world's most walkable city. But for those who can't make travel to Europe a reality ...